Transparent Cap-assisted Endoscopic Sclerotherapy

Status Completed

Clinical Trial Summary

The aim of this study is to evaluate efficacy and safety of transparent cap-assisted endoscopic sclerotherapyI(lauromacrogol injection) in management of esophageal varices.

Clinical Trial Description

Endoscopic procedures now play a great role in management of esophagogastric varices. Endoscopic variceal ligation(EVL) was recommended as first line therapy for primary and secondary prophylaxis in patients with esophageal varices. Previous studies have showed a superiority of EVL over endoscopic injection of sclerotherapy(EIS), mainly because of lower occurrence rate of complications. Procedure related complications were related to total amount of lauromacrogol, number of treatment and expertise of the endoscopists. Transparent cap has already been reported to assist in other endoscopic procedures, such as biopsy of Barret esophagus or endoscopic submucosal dissection. Accuracy and vision were improved with the help of transparent cap in the front of endoscopy. We have tried transparent cap-assisted sclerotherapy in some patients with in our hospital. Now a randomized controlled trial was conducted to evaluate efficacy and safety of transparent cap-assisted endoscopic sclerotherapy in management of esophageal varices. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02361593
Study type	Interventional
Source	Shanghai Zhongshan Hospital
Contact
Status	Completed
Phase	N/A
Start date	April 2015
Completion date	December 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06017102` - Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices	N/A
Recruiting	`NCT03624517` - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices	Phase 4
Recruiting	`NCT03989973` - Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
Completed	`NCT05485714` - Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
Completed	`NCT01851252` - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy	Phase 1
Completed	`NCT01360515` - A Study of Disposable Transnasal Esophagoscope	N/A
Recruiting	`NCT04602663` - Optimal Time for Follow up After Variceal Band Ligation	N/A
Recruiting	`NCT04499898` - Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding	Phase 2/Phase 3
Completed	`NCT00331188` - Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding	Phase 3
Enrolling by invitation	`NCT02767206` - Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.	N/A
Enrolling by invitation	`NCT05781828` - Noninvasive Methods For Prediction of Esophageal Varices in Children
Not yet recruiting	`NCT05199038` - Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study	Phase 4
Recruiting	`NCT02740166` - Preventing Recurrent Bleeding After Eradication of Esophageal Varices	Phase 4
Completed	`NCT01893541` - PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?	Phase 4
Terminated	`NCT00485290` - Effect of Meal on Portal and Esophagus Variceal Pressure	N/A
Completed	`NCT01079416` - Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices	N/A
Completed	`NCT01188733` - Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis	Phase 1/Phase 2
Not yet recruiting	`NCT04254822` - HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients	N/A
Recruiting	`NCT03212872` - Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding	N/A
Completed	`NCT03748563` - Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis	N/A